GSK232802
- Generic Name
- GSK232802
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H28O3
- CAS Number
- 843661-24-5
- Unique Ingredient Identifier
- AG92SGO434
- Background
GSK232802 is under investigation in clinical trial NCT00604825 (Treatment of Hot Flashes/flushes in Postmenopausal Women (WARM Study)).
- Associated Conditions
- -
- Associated Therapies
- -
Menopause Treatment Market 2034: Clinical Trials, EMA, PDMA
DelveInsight's Menopause Market Insights, Epidemiology, and Market Forecast-2034 report analyzes market trends, epidemiology, and emerging therapies in the US, EU4, UK, and Japan. Key companies include GlaxoSmithKline, Pfizer, Bayer, and others. The market size was ~USD 10,968 million in 2022, with hormonal therapy dominating but expected to decline as non-hormonal therapies gain prevalence. Notable therapies include VEOZAH, a non-hormonal treatment approved by the FDA in 2023.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath